Central Insurance (DHA:CENTRALINS) Research & Development: BDT0.0 Mil (TTM As of Mar. 2026)


DHA:CENTRALINS Central Insurance PLC DHA:CENTRALINS
81 GF Score
Price BDT42.50
GF Value BDT42.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Central Insurance Research & Development?

Central Insurance DHA:CENTRALINS +2.91% 81 Research & Development is BDT0.0 Mil as of Mar. 2026. GuruFocus rates DHA:CENTRALINS with a GF Score™ of 81/100 and a GF Value™ of BDT42.49 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Central Insurance's Research & Development for the three months ended in Mar. 2026 was BDT0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was BDT0.0 Mil.

Central Insurance  (DHA:CENTRALINS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Central Insurance Research & Development Related Terms

Central Insurance Research & Development Historical Data

* Premium members only.

The historical data trend for Central Insurance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Insurance Research & Development Chart

Central Insurance Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Central Insurance Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DHA:CENTRALINS
81GF Score
Central Insurance PLC DHA:CENTRALINS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Insurance Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT0.0 Mil mean?
Central Insurance (DHA:CENTRALINS) has a Research & Development of BDT0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Central Insurance and its competitors.
Is Central Insurance's Research & Development too high?
Central Insurance's current Research & Development is BDT0.0 Mil. Overall, Central Insurance has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Central Insurance's Research & Development compare to CB and PGR?
Central Insurance's Research & Development of BDT0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Central Insurance and its competitors. Central Insurance's current Research & Development is BDT0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Insurance stock overvalued right now?
Based on GuruFocus' analysis, Central Insurance (DHA:CENTRALINS) is currently considered Fairly Valued. The stock's GF Value™ is BDT42.49, compared to a current price of BDT42.50 — trading 0% above its estimated fair value. The current Research & Development is BDT0.0 Mil. Central Insurance's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Central Insurance (DHA:CENTRALINS), the current Research & Development is BDT0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Central Insurance (DHA:CENTRALINS) Overvalued in 2026?

Based on GuruFocus' analysis, Central Insurance stock appears to be overvalued. The current stock price of BDT42.50 is trading 0% above its estimated GF Value™ of BDT42.49. GuruFocus considers Central Insurance to be Fairly Valued.

Key valuation signals for DHA:CENTRALINS:

  • Research & Development: BDT0.0 Mil
  • GF Value™: BDT42.49 vs. price of BDT42.50 (0% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the DHA:CENTRALINS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Central Insurance Business Description

Address No. 7-8 Motijheel C/A, Central Insurance Bhaban, CIC Tower, 3rd and 4th Floor, Dhaka, BGD, 1000
Central Insurance PLC is a Non-life Insurance Company, engaged in the business of providing all kinds of non-life insurance products and services in Bangladesh. Its products and services include: Fire Insurance, Marine Cargo, Marine Hull, Engineering, Overseas Mediclaim and Holiday, Motor, Various Liability, Aviation Hull and Liability and Miscellaneous Insurances.
81GF Score

Get the complete analysis for DHA:CENTRALINS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT42.50
Price
BDT42.49
GF Value